The investment will expand Resilience’s U.S. capacity to make the KwikPen device Eli Lilly uses to deliver its injectable diabetes and obesity medicines.
Moderna’s norovirus vaccine failed in a Phase 3 trial, but the company still has faith in an ambitious revenue growth target thanks to ex-U.S. vaccine sales and a unanimous FDA adcomm win for mFLUSIVA.
Alnylam’s revenue cut “may create a near term credibility overhang and could “raise questions on peak sales potential, even if there’s tailwinds in the competitive landscape,” according to Stifel.
The IRS’s Criminal Investigation unit issued a fraud alert warning about scammers who are targeting cryptocurrency holders with convincing fake IRS letters.
The Senate Finance Committee voted nearly unanimously to approve a wide-ranging bipartisan tax administration bill aimed at improving operations at the IRS.